Eleftherios Mylonakis is an Infectious Disease physician affiliated with Houston Methodist. OpenAlex indexes 567 publications with 32,372 citations (h-index 93); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St Ste 1001
Houston, TX 770302740
Telephone
617-670-9115Provider last certified this registry record 23 Jun 2023.
Clinical trials
- Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
Sponsor: Rhode Island Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shionogi IncProgram year20251 payment
- Seqirus USA IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- Natural Phenolic Compounds against Oral Candidiasis (OC)
Methodist Hospital Research Institute
FY2026$401,021R01AI181635 - Pro-CanDy (Probiotic-Loaded Hydrogels for the Prevention and Management of Oral Candidiasis and Dysbiosis)
Methodist Hospital Research Institute
FY2026$363,375R01DE035829 - Natural Phenolic Compounds against Oral Candidiasis (OC)
Methodist Hospital Research Institute
FY2025$401,021R01AI181635
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020
Clinical Gastroenterology and Hepatology
2023 - A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant <i>Staphylococcus aureus</i>
Proceedings of the National Academy of Sciences
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Bita Esmaeli, MD
Houston Methodist
Sherif Nagueh, MD
Houston Methodist
Neal Kleiman, MD
Houston Methodist
Miguel Quinones, MD
Houston Methodist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”